GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study
Francesca Bonifazi(University of Bologna), Nicolaus Kröger(Universität Hamburg), Angelo Michele Carella(San Antonio College), Wolfgang Bethge(University of Tübingen), Jorge Sierra(Universitat Autònoma de Barcelona), Carmine Selleri(Ospedali Riuniti San Giovanni di Dio e Ruggi d'Aragona), Tapani Ruutu(Helsinki University Hospital), Domenico Russo, Jürgen Finke(University Medical Center Freiburg), Elisabetta Terruzzi(Azienda Ospedaliera San Gerardo), Mariarosaria Sessa(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Antonio M. Risitano(European Society for Blood and Marrow Transplantation), Pilar Herrera(Hospital Universitario Ramón y Cajal), Andreas Völp(Sahlgrenska University Hospital), Francesca Patriarca(Ospedale Santa Maria della Misericordia di Udine), Fabio Benedetti(Azienda Ospedaliera Universitaria Integrata Verona), Arnon Nagler(Sheba Medical Center), Marion Heinzelmann(Universität Hamburg), E. Benedetti(University of Illinois Chicago), Francesco Zallio(Azienda Sanitaria Locale Alessandria), Christine Wolschke(Universität Hamburg), Giuseppe Milone(University of Catania), Domenico Pastore(Istituto di Ematologia di Bologna), Carlos Solano(Hospital Clínico Universitario de Valencia), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Michele Cimminiello(Ospedale San Carlo), Franco Narni(Azienda Ospedaliero-Universitaria di Modena), Francis Ayuk(Universität Hamburg), Roberto Sorasio(Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo), Manuel Jurado, Christelle Ferrá(Hospital Universitari Germans Trias i Pujol), Stefano Guidi(Universität Hamburg), Giuseppe Messina(Collegio Carlo Alberto)
Cited by 58
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k